SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $200

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.

Total
0
Shares
Related Posts